Indication
Comorbidities and Coexisting Conditions
2 clinical trials
6 products
Clinical trial
The Most Appropriate Prescription of the First-line, the Second-line, and the Third Treatment for H. Pylori Eradication Among Patients Who Are Comorbid Diabetes Mellitus, Chronic Obstructive Pulmonary Disease, or Chronic Kidney DiseaseStatus: , Estimated PCD: 2023-12-31
Product
The sequential therapyProduct
The triple therapyProduct
The Hybrid TherapyProduct
The concomitant therapyClinical trial
An Observational, Prospective Study on the Integrated Disease Management Effectiveness of COPD and Related Comorbidities in XishuiStatus: Not yet recruiting, Estimated PCD: 2025-10-15